Y-mAbs Therapeutics MACD Death Cross Triggers Amid RSI Overbought Signal.

Y-mAbs Therapeutics' 15-minute chart has recently exhibited a MACD Death Cross and RSI Overbought indicator at 08/05/2025 13:15. This suggests that the stock price has the potential to continue declining, as it has risen rapidly and surpassed its fundamental support levels.

Y-mAbs Therapeutics Inc. (YMAB) has seen a significant upward movement in its stock price, with a 103.34% increase on Tuesday, August 5, 2025 [1]. The stock price rose from $4.19 to $8.52, marking a substantial gain over the last trading day. However, recent technical indicators suggest a potential downward trend.

On August 5, 2025, at 13:15, Y-mAbs Therapeutics' 15-minute chart exhibited a MACD Death Cross and an RSI Overbought indicator. The MACD Death Cross, which occurs when the MACD line crosses below the signal line, is typically seen as a bearish signal, indicating a potential reversal in the stock's upward trend [2]. The RSI (Relative Strength Index) Overbought indicator, with an RSI14 value of 84, suggests that the stock is overvalued and may be due for a correction [1].

The combination of these indicators suggests that Y-mAbs Therapeutics' stock price has the potential to continue declining. The rapid rise in the stock price has surpassed its fundamental support levels, and the MACD Death Cross indicates a possible reversal in the trend. The RSI Overbought indicator further supports this view, as it suggests that the stock is overvalued and may be due for a correction.

Investors should be cautious and closely monitor the stock's performance in the coming days. The stock may experience a significant correction due to the overbought condition, and the MACD Death Cross suggests a potential downward trend. However, it is essential to note that technical indicators should be used in conjunction with fundamental analysis to make informed investment decisions.

References:
[1] https://stockinvest.us/stock/YMAB
[2] https://www.stocktitan.net/news/YMAB/